Unveiling cancer in IBD: Screening colonoscopy or chromoendoscopy

Current Drug Targets

Volumn 13, Issue 10, 2012, Pages 1268-1272

  Repici, Alessandro ^a   Laterra, Maria Antonella ^b   Cisarò, Fabio ^b   Pellicano, Rinaldo ^b   Fini, Lucia ^a   Ishaq, Sauid ^c  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c RUSSELLS HALL HOSPITAL   (United Kingdom)

Author keywords

Cancer; Chromoendoscopy; Colonoscopy; IBD; Screening

Indexed keywords

CANCER EPIDEMIOLOGY; CANCER SCREENING; CHROMOENDOSCOPY; COLONOSCOPY; COLORECTAL CANCER; DYSPLASIA; ENTERITIS; HUMAN; IMAGE ANALYSIS; MAGNIFYING ENDOSCOPY; NARROW BAND IMAGING; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS;

COLONIC NEOPLASMS; COLONOSCOPY; HUMANS; INFLAMMATORY BOWEL DISEASES;

EID: 84866550407     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/138945012802429660     Document Type: Review

References (33)

1. Calkins BM, Lilienfeld AM, Garland CF, Mendeloff AI. Trends in incidence rates of ulcerative colitis and Crohn's disease. Dig Dis Sci 1984; 29(10): 913-20.
2. Abraham C, Cho JH. Inflammatory Bowel Disease. N Engl J Med 2009; 361: 2066-78.
3. Mudter J, Neurath MF. Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications. Gut 2007; 56: 293-303.
4. Lennard-Jones JE, Morson BC, Ritchie JK, Williams CB. Cancer surveillance in ulcerative colitis: experience over 15 years. Lancet 1983; 2: 149-52.
5. Ullman T, Odze R, Farraye FA. Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn's disease of the colon. Inflamm Bowel Dis 2009; 15: 630-8.
6. Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004; 126(2): 451-9.
7. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001; 48(4): 526-35.
8. Freeman HJ. Surveillance for colitis-associated colon neoplasia. World J Gastroenterol 2010; 16(37): 4646-51
9. Mattar MC, Lough D, Pishvaian MJ, Charabaty A. Current management of inflammatory Bowel Disease and Colorectal Cancer. Gastrointest Cancer Res 2011; 4: 53-61.
10. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983; 14: 931-68.
11. Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? The Lancet 1994; 343(8889): 71-4.
12. Ullman T, Odze R, Farraye FA. Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn's disease of the colon. Inflamm Bowel Dis 2009; 15: 630-8.
13. Rubin PH, Fiedman S, Harpaz N, et al. Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology 1999; 117: 1295-300.
14. Itzkowitz SH, Present DH. Consensus conference: Colorectal Cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2005; 11(3): 314-321.
15. Biancone L, Travis S, Escher JC, et al. European evidence based consensus on the management of ulcerative colitis: special situations. J Crohn Colitis 2008; 2: 63-92.
16. Eaden JA, Mayberry JF. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 2002; 51(suppl 5): V10-12.
17. Claessen MM, Siersema PD, Vleggaar FP. IBD related carcinoma and lymphoma. Best Practice and Research Clinical Gastroenterology 2011; 25(Suppl. 1): S27-S38.
18. Collins PD, Mpofu C, Watsonm AJ, Rhodes JM. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev 2006; 2: CD000279.
19. Neurath MF, Kiesslich R. Is chromoendoscopy the new standard for cancer urveillance in patients with ulcerative colitis? Nat Clin Pract Gastroenterol Hepatol 2009; 6: 134-5.
20. Kiesslich R, Galle PR, Neurath MF. Endoscopic surveillance in ulcerative colitis: smart biopsies do it better. Gastroenterology 2007; 133: 742-5.
21. Kiesslich R, Fritsch J, Holtmann M, et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003; 124: 880-8.
22. Rutter MD, Saunders BP, Schofield G, Forbes A, Price AB, Talbot IC. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 2004; 53(2): 256-60.
23. Marion JF, Waye JD, Present DH, et al. Chromoendoscopytargeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatorybowel disease patients: a prospective endoscopic trial, Am Journ of Gastroenterology 2008; 103(9): 2342-9.
24. Wu L, Li P, Wu J, Cao Y, Gao F. The diagnostic accuracy of chromoendoscopy for dysplasia in ulcerative colitis: meta-analysis of six randomized controlled trials. Colorectal Dis 2010; 14(4): 416-20.
25. Farraye FA, Odze RD, Eaden J, et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 2010; 138: 738-45.
26. East JE, Suzuki N, von HA, Saunders BP. Narrow band imaging with magnification for dysplasia detection and pit pattern assessment in ulcerative colitis surveillance: a case with multiple dysplasia associated lesions or masses. Gut 2006; 55: 1432-5.
27. Matsumoto T, Kudo T, Jo Y, Esaki M, Yao T, Iida M. Magnifying colonoscopy with narrow band imaging system for the diagnosis of dysplasia in ulcerative colitis: a pilot study. Gastrointest Endosc 2007; 66: 957-65.
28. Van den Broek FJC, Reitsma JB, Cruvers WL, Fockens P, Dekker E. Systematic review of narrow-band imaging for the detection of neoplastic and nonneoplastic lesions in the colon. Gastrointest Endosc 2009; 69: 124-35.
29. Dekker E, van den Broek FJ, Reitsma JB, et al. Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis. Endoscopy 2007; 39: 216-21.
30. Pellisé M, López-Cerón M, Rodríguez de Miguel C, et al. Narrowband imaging as an alternative to chromoendoscopy for the detection of dysplasia in long-standing inflammatory bowel disease: a prospective, randomized, crossover study. Gastrointest Endosc 2011; 74(4): 840-8.
31. van den Broek FJ, Fockens P, van Eeden S, et al. Narrow-band imaging versus high-definition endoscopy for the diagnosis of neoplasia in ulcerative colitis. Endoscopy 2011; 43(2): 108-15.
32. Hoffman A, Sar F, Goetz M, et al. High definition colonoscopy combined with i-Scan is superior in the detection of colorectal neoplasias compared with standard video colonoscopy: a prospective randomized controlled trial. Endoscopy 2010; 42(10): 827-33.
33. Hurlstone DP, Sanders DS, Lobo AJ, McAlindon ME, Cross SS. Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation, Endoscopy 2005; 37(12): 1186-92.